367 related articles for article (PubMed ID: 36230810)
1. Colorectal Cancer and Purinergic Signalling: An Overview.
Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
[TBL] [Abstract][Full Text] [Related]
2. Targeting the purinergic pathway in breast cancer and its therapeutic applications.
de Araújo JB; Kerkhoff VV; de Oliveira Maciel SFV; de Resende E Silva DT
Purinergic Signal; 2021 Jun; 17(2):179-200. PubMed ID: 33576905
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA: Crucial modulator in purinergic signalling involved diseases.
Guo J; Yang P; Li YF; Tang JF; He ZX; Yu SG; Yin HY
Purinergic Signal; 2023 Mar; 19(1):329-341. PubMed ID: 35106737
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
de Andrade Mello P; Coutinho-Silva R; Savio LEB
Front Immunol; 2017; 8():1526. PubMed ID: 29184552
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signaling: Diverse effects and therapeutic potential in cancer.
Kaur J; Dora S
Front Oncol; 2023; 13():1058371. PubMed ID: 36741002
[TBL] [Abstract][Full Text] [Related]
6. Purinergic signaling: A gatekeeper of blood-brain barrier permeation.
Wang Y; Zhu Y; Wang J; Dong L; Liu S; Li S; Wu Q
Front Pharmacol; 2023; 14():1112758. PubMed ID: 36825149
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signaling during intestinal inflammation.
Longhi MS; Moss A; Jiang ZG; Robson SC
J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
[TBL] [Abstract][Full Text] [Related]
8. Purinergic signaling in liver disease.
Vaughn BP; Robson SC; Longhi MS
Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
[TBL] [Abstract][Full Text] [Related]
9. P2 purinergic receptors regulate the progression of colorectal cancer.
Zhang WJ; Zhang LP; Lin SJ; Wang CY; Le YG
Purinergic Signal; 2023 Dec; ():. PubMed ID: 38153612
[TBL] [Abstract][Full Text] [Related]
10. Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer.
Künzli BM; Bernlochner MI; Rath S; Käser S; Csizmadia E; Enjyoji K; Cowan P; d'Apice A; Dwyer K; Rosenberg R; Perren A; Friess H; Maurer CA; Robson SC
Purinergic Signal; 2011 Jun; 7(2):231-41. PubMed ID: 21484085
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of purinergic signaling in anti-cancer therapy resistance.
Zanoni M; Pegoraro A; Adinolfi E; De Marchi E
Front Cell Dev Biol; 2022; 10():1006384. PubMed ID: 36200041
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.
Künzli BM; Berberat PO; Giese T; Csizmadia E; Kaczmarek E; Baker C; Halaceli I; Büchler MW; Friess H; Robson SC
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G223-30. PubMed ID: 16920697
[TBL] [Abstract][Full Text] [Related]
13. Uncaria tomentosa extract alters the catabolism of adenine nucleotides and expression of ecto-5'-nucleotidase/CD73 and P2X7 and A1 receptors in the MDA-MB-231 cell line.
Santos KF; Gutierres JM; Pillat MM; Rissi VB; Santos Araújo MD; Bertol G; Gonçalves PB; Schetinger MR; Morsch VM
J Ethnopharmacol; 2016 Dec; 194():108-116. PubMed ID: 27590731
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
16. Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine.
Dillard C; Borde C; Mohammad A; Puchois V; Jourdren L; Larsen AK; Sabbah M; Maréchal V; Escargueil AE; Pramil E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768902
[TBL] [Abstract][Full Text] [Related]
17. Purinergic Receptors in Thrombosis and Inflammation.
Hechler B; Gachet C
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
[TBL] [Abstract][Full Text] [Related]
18. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
[TBL] [Abstract][Full Text] [Related]
19. Purinoceptors in inflammation: potential as anti-inflammatory therapeutic targets.
Ferrero ME
Front Biosci (Landmark Ed); 2011 Jun; 16(6):2172-86. PubMed ID: 21622169
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils: fast and furious-the nucleotide pathway.
Rubenich DS; de Souza PO; Omizzollo N; Lenz GS; Sevigny J; Braganhol E
Purinergic Signal; 2021 Sep; 17(3):371-383. PubMed ID: 33913070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
